United States

United States

Oral Vaccination to Control Specific Rabies Virus Variants – EA (PDF 2.38MB)

Oral Vaccination to Control Specific Rabies Virus Variants - FONSI (PDF 25.37MB)

Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia (EA) (PDF 3MB)

Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia (Decision/FONSI) (PDF 598KB)

2012 Supplement to the Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia (PDF 2.18MB)

2012 Decision and Finding of no Significant Impact for the Supplement to the Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia (PDF 3.08MB)

2013 Environmental Assessment Supplement: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia (PDF 2.18MB)

2013 Decision and Finding of no Significant Impact for the Supplement to the Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 Vector in New Hampshire, New York, Ohio, Vermont, and West Virginia (PDF 305KB)

2015 Supplement to the Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 in New Hampshire, NewYork, Ohio, Vermont, and West Virginia  (PDF; 1.49MB)

2015 Decision/ FONSI for the Supplement to the Environmental Assessment: Field Trial of an Experimental Rabies Vaccine, Human Adenovirus Type 5 in New Hampshire, New York, Ohio, Vermont, and West Virginia  (PDF; 172KB)

 

 


Complementary Content
${loading}